Esperion Therapeutics, Inc. · NASDAQ:ESPR

BB Biotech AG reported a 5.00% stake in Esperion Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

BB Biotech AG reported a 5.00% stake in Esperion Therapeutics, Inc., 9,944,064 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
5.00%
Shares
9,944,064
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
BB Biotech AG5.00%9,944,064
Biotech Target N.V.5.00%9,944,064

Source

View original at SEC

Related